1. Home
  2. IBTA vs XOMA Comparison

IBTA vs XOMA Comparison

Compare IBTA & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ibotta Inc.

IBTA

Ibotta Inc.

HOLD

Current Price

$35.57

Market Cap

750.2M

Sector

N/A

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$42.94

Market Cap

746.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBTA
XOMA
Founded
2011
1981
Country
United States
United States
Employees
N/A
14
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
750.2M
746.0M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
IBTA
XOMA
Price
$35.57
$42.94
Analyst Decision
Hold
Buy
Analyst Count
7
4
Target Price
$28.50
$52.50
AVG Volume (30 Days)
155.1K
123.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,389,000.00
N/A
Revenue This Year
$2.02
$24.59
Revenue Next Year
$8.96
N/A
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$19.10
$22.29
52 Week High
$41.14
$43.00

Technical Indicators

Market Signals
Indicator
IBTA
XOMA
Relative Strength Index (RSI) 61.66 73.91
Support Level $34.61 $40.76
Resistance Level $40.49 N/A
Average True Range (ATR) 1.85 0.45
MACD 0.53 0.02
Stochastic Oscillator 94.32 100.00

Price Performance

Historical Comparison
IBTA
XOMA

About IBTA Ibotta Inc.

Ibotta Inc operates a digital promotions platform, the Ibotta Performance Network (IPN), which connects consumer packaged goods (CPG) brands with consumers through a network of publishers. It sources digital offers from clients and distributes them via its technology platform, earning revenue when promotions result in consumer transactions. The platform supports offers across grocery and general merchandise categories, including toys, clothing, beauty, electronics, pet, and home products. The majority of its revenues is derived from the fees charged to clients when consumers redeem offers on the IPN by purchasing promoted products.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Share on Social Networks: